Myelodysplastic Syndrome associated TET2 mutations affect NK cell function and genome methylation
Maxime Boy(University of London Institute in Paris), Nicolas Dulphy(Inserm), Emilie Lereclus(Centre National de la Recherche Scientifique), Valéria Bisio(University of London Institute in Paris), Christelle Retière(Centre National de la Recherche Scientifique), Pierre Fenaux(Hôpital Avicenne), Guylaine Henry(Assistance Publique – Hôpitaux de Paris), Juliette Villemonteix(Assistance Publique – Hôpitaux de Paris), Emmanuelle Clappier(Inserm), Rathana Kim(Centre National de la Recherche Scientifique), Katia Gagne(Inserm), O. Fain(Sorbonne Université), Lise Larcher(Centre National de la Recherche Scientifique), Marie Sébert(Assistance Publique – Hôpitaux de Paris), Fabien Guidez(Inserm), Karl Balabanian(Inserm), Lin‐Pierre Zhao, Anne Caignard(Inserm), Bérénice Schell(Université Paris Cité), Marion Espéli(University of Cambridge), Fernando Rodrigues‐Lima(Inserm), Antoine Toubert(Inserm), A. Mékinian(Assistance Publique – Hôpitaux de Paris), Lionel Adès(Délégation Paris 7)
Cited by 39
Related Papers
Diagnosis and management of AML in adults: 2017 ELN recommendations from an international expert panel
|Blood|2016|5.9k
Diagnosis and management of AML in adults: 2022 recommendations from an international expert panel on behalf of the ELN
|Blood|2022|3k
Insertional oncogenesis in 4 patients after retrovirus-mediated gene therapy of SCID-X1
|Journal of Clinical Investigation|2008|1.8k